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Abstract
Background: Oral health complications in diabetes and hypertension include decreased salivary secretion. The
sodium-glucose cotransporter 1 (SGLT1) protein, which transports 1 glucose/2 Na+/264 H2O molecules, is described
in salivary glands. We hypothesized that changes in SGLT1 expression in the luminal membrane of ductal cell may
be related to an altered salivary flow.
Findings: By immunohistochemistry, we investigated SGLT1 expression in ductal cells of parotid and submandibular
glands from Wistar Kyoto rats (WKY), diabetic WKY (WKY-D), spontaneously hypertensive rats (SHR) and diabetic
SHR (SHR-D), as well as in parotid glands from WKY subjected to sympathetic stimulation, with or without previous
propranolol blockade. Diabetes and hypertension decreased the salivary secretion and increased SGLT1 expression
in the luminal membrane of ductal cells, and their association exacerbated the regulations observed. After 30 min of
sympathetic stimulation, SGLT1 increased in the luminal membrane of ductal cells, and that was blocked by previous
injection of propranolol.
Conclusions: SGLT1 expression increases in the luminal membrane of salivary gland ductal cells and the salivary flow
decreases in diabetic and hypertensive rats, which may be related to sympathetic activity. This study highlights the
water transporter role of SGLT1 in salivary glands, which, by increasing ductal water reabsorption, may explain the
hyposalivation of diabetic and hypertensive subjects.
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Background
Reduced salivary flow rate has been described in diabetes
[1,2], as well as in hypertension [3]; two diseases that are
frequently associated. Salivary gland function is highly
controlled by both the sympathetic and the parasympa-
thetic activity [4], which may be impaired in both diabetes
and hypertension.
According to the classical two-stage hypothesis of saliva
production [5], a primary fluid containing plasma-like elec-
trolyte concentration is generated by the acinar cells. The
fluid is subsequently modified as it flows along the ductal
system, resulting in the final, hypotonic solution that enters
the mouth [6]. In this process, for the last half century, acini
have been considered as the main site of water transport,
with no relevant water flow in ducts [5]; however, that has
never been clearly demonstrated. Besides, the study of
transepithelial glucose and water fluxes in the ductal
cells under pathological conditions has been ignored.
The sodium glucose cotransporter SGLT1 plays an
essential role in absorbing glucose from diet in the
intestine, and an adjuvant role in reabsorbing glucose
from the glomerular filtrate in kidneys [7]. Recently, a
powerful role of water transport has been additionally
attributed to SGLT1, once the stoichiometric relationship
of transport capacity was observed to be 2 Na+: 1 glucose:
264 H2O molecules [7,8].
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In salivary glands, the SGLT1 protein was initially
described in the basolateral membrane of acinar cell
[9], where it provides glucose for the cellular metabolism
[10]. Furthermore, the SGLT1 expression in acinar cells
has already been described as altered in diabetes and
hypertension, in a sympathetic-mediated way [10]. Recently,
the SGLT1 protein has been demonstrated in the luminal
membrane of ductal cells of salivary glands as well [11,12],
and changes in its expression have been suggested to
be involved in the diabetes-induced alterations of the
salivary flow (12). However, the effects of hypertension
and its association to diabetes in ductal SGLT1 expression,
as well as in the resulting changes in salivary glucose
concentration and the salivary flow, remain unknown.
Thus, the aims of the present study were to investigate,
in ductal cells of salivary glands from diabetic and
hypertensive rats: 1) the SGLT1 protein expression and
subcelular localization; 2) the sympathetic activity upon
the SGLT1 translocation to the luminal membrane; and
3) the correlation between changes in SGLT1 and the
salivary flow.
Methods
All experimental procedures were approved by the
Ethical Committee for Animal Research of the Institute
of Biomedical Sciences (University of São Paulo, Proto-
col #97/2007). The study was performed in male Wistar
Kyoto (WKY) and Spontaneously Hypertensive (SHR)
rats (weighing ~260 g). Part of the animals was rendered
diabetic (WKY-D or SHR-D) by intravenous injection of
alloxan (40 mg/Kg body weight), and studied after 30 days.
Five animals per group of diabetic and hypertensive
rats were analyzed, plus 6 animals for acute sympathetic
stimulation analysis, totaling 26 animals.
Arterial pressure was measured in unanaesthetized
animals, as previously described [10]. To determine the
sympathetic role upon the SGLT1 protein intracellular
traffic, stimulation of the left postganglionic sympathetic
nerve was performed in a group of anaesthetized WKY
rats (sodium pentobarbital, 40 mg/kg, ip), in the presence
or absence of a β-blocker propranolol (2 mg/kg, iv), as
previously described [10]. The glands were harvested
30 min after the stimulus.
Non-stimulated salivary secretion was measured in
anaesthetized rats (sodium pentobarbital, 40 mg/kg, ip)
for 7 min, using four pre-weighed cotton balls inserted
into the oral cavity, two underneath the tongue, and
two bilaterally medial to the teeth and oral mucosa.
The 7-min volume of secreted saliva was calculated by
subtracting the initial from the final weight of the cotton
balls, and considering that 1 mg corresponds to 1 μL.
After that, still under anaesthesia, blood was sampled
from the tail vein, and the parotid and submandibular
glands were harvested for further immunohistochemistry
analysis.
Immunohistochemistry
Immunohistochemistry analysis was performed as previ-
ously described [12]. Briefly, tissue sections were incubated
with anti-SGLT1 antibody (1:50; Chemicon International).
After washing with PBS, tissues were incubated with
goat antiserum against rabbit IgG tagged to Cy5 (1:200;
Molecular Probes, Eugene, OR). Rhodamin-phalloidin
(1:100; Molecular Probes) and Sitox Green (1:10,000;
Molecular Probes) were incubated to stain F-actin and
nucleous; respectively. The slides were mounted and
viewed under a confocal microscope (Nikon PCM2000).
Glucose concentration was measured in plasma, saliva
and urine, using the kit Glicose Enzimática (ANALISA
Diagnostica, Belo Horizonte, MG, Brazil).
Results are presented as mean ± SEM, and statistical
analysis was performed by One-Way analysis of Variance
(ANOVA) and Student-Newman-Keuls as a post-test, using
the GraphPad Prism version 4.00 system (GraphPad
Software, San Diego, CA, USA).
Results
WKY and SHR diabetic or non-diabetic rats presented
the general characteristics expected for these models,
which are shown as supplementary material (Additional
file 1: Table S1). Part of the general parameters of this
study was presented previously [10]. SHR were hypertensive,
and diabetes did not change this feature.
Salivary secretion (Table 1) was reduced in SHR, and
diabetes induced an additional reduction. Salivary secretion
was also reduced by diabetes in WKY rats. The salivary
glucose concentration (Table 1) was lower in SHR than in
WKY, an aspect never described before, and, as expected,
diabetes increased it in both SHR-D and WKY-D.
Figure 1A shows the presence of the SGLT1 protein
in ductal cells of the submandibular gland, as well as
its subcellular localization. In glands from WKY rat,
immunofluorescence does not show important staining
in the luminal membrane of ductal cells (A and E).
However, in glands from diabetic (B and F) and hyper-
tensive (C and G) rats, the SGLT1 protein is clearly
observed in the luminal membrane of ductal cells. The
association of diabetes and hypertension induced an
additional expression of the SGLT1 protein in the luminal
membrane, as well as a diffuse intracellular expression
(E-H). Similar result was observed in the parotid gland
(Additional file 2: Figure S1).
To verify the sympathetic activity role upon the SGLT1
protein translocation from the intracellular to the luminal
membrane of ductal cells, we performed immunohisto-
chemical analysis of non-stimulated and sympathetically
stimulated parotid glands of non-diabetic WKY rats,
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subjected or not to previous β-blockade with propranolol
(Figure 1B). In non-stimulated parotid glands, immuno-
fluorescence does not reveal the SGLT1 protein in the
luminal membrane of ductal cells (A and E), as described
above. After 30 minutes of sympathetic stimulus, the
SGLT1 protein content increased in the luminal membrane,
demonstrating that the sympathetic activity induced the
SGLT1 translocation (B and F). In basal (non-stimulated)
parotid glands of propranolol-treated rats (C and G), only
a low intracellular spread staining is observed, indicating
that the β-blockade reduced the basal expression of the
SGLT1 protein. Additionally, in the parotid glands from
propranolol-treated rats subjected to sympathetic stimulus,
the SGLT1 staining remained diffuse intracellularly,
and did not appear near the luminal membrane of ductal
cells (D and H).
Discussion
In the present study, we demonstrate changes in the
SGLT1 protein expression in salivary glands which can
explain alterations in the salivary secretion observed in
diabetic and hypertensive subjects. Considering the high
capacity of SGLT1 to transport water [8], the increase
in this protein at the luminal membrane of ductal cells
observed in diabetic and hypertensive rats is in accordance
with the decreased salivary flow rate detected in these
animals. Thus, the inversely proportional regulation of the
luminal SGLT1 content and of the salivary flow points out
that this transporter is involved in the pathophysiology of
diabetic and hypertensive xerostomia. In the acinar cells of
salivary glands, where the SGLT1 protein plays a role in
the cellular glucose disposal, similar regulations have been
described in diabetic and hypertensive rats [10]. However,
changes in the acinar SGLT1 expression do not contribute
to the final salivary glucose concentration and salivary
flow, as much as the changes in the luminal content of
ductal cell shown here do.
Participation of the β-adrenergic activity in the SGLT1
expression and localization has already been described
in acinar cells [10], and now, for the first time, we dem-
onstrate the β-adrenergic role in the SGLT1 expression
and translocation to the luminal membrane of ductal
cells, where it must play a fundamental role in water
reabsorption and; consequently; in the salivary flow.
It is important to point out that hypertensive rats (SHR)
have a high sympathetic drive to the salivary glands [10],
and this can explain the increased luminal content and
cellular expression of SGLT1 observed in these animals.
However, diabetes decreases the sympathetic activity in
the salivary glands [10], but the luminal content of SGLT1
is increased in glands from both WKY and SHR diabetic
rats, which implies an additional mechanism of regulation
of the SGLT1 translocation. In this respect, the expression
of a sugar sensor, which, via a G-protein-coupled receptor
(GPCR), enhances SGLT1 translocation into the luminal
membrane, was reported in the epithelial cells from the
proximal intestine [13,14] and pancreatic ducts [15].
Considering that this glucose–sensing GPCR system
might be expressed in the luminal membrane of ductal
cells of salivary glands, high glucose concentration in
primary saliva of diabetic rats could, therefore, explain
the increased SGLT1 protein translocation, in spite of the
decreased sympathetic activity. However, it is important to
point that, although diabetes decreases the salivary gland
sympathetic activity, in hypertensive rats it is still elevated
as compared with normal rats [10]. Thus, the additional
SGLT1 staining in the luminal membrane observed in
ductal cells of diabetic SHR could be a consequence of a
dual activation of PKA: by the high sympathetic activity
and by the high luminal glucose concentration.
Glucose concentration in the primary saliva is closely
related to plasma glucose concentration; nevertheless,
glucose concentration in the final saliva of diabetic subjects
has not been significantly correlated to their hyperglycemia
[16,17]. In the present study, data from hypertensive rats
point out the functional role of SGLT1 in the luminal
membrane of ductal cells as a modulator of salivary
glucose xconcentration. In SHR, the luminal SGLT1
increased in ductal cells, and the salivary glucose con-
centration decreased, as compared to WKY, in spite of the
similar plasma glucose concentration, and the reduced
salivary volume. On the other hand, in diabetic WKY
and SHR, the glucose concentration was high in the
final saliva, despite the expected increase in glucose
Table 1 Morphological and functional characteristics of salivary glands of Wistar Kyoto (WKY) rats, diabetic WKY
(WKY-D), spontaneously hypertensive rats (SHR) and diabetic SHR (SHR-D)
WKY WKY-D SHR SHR-D
Parotid weight (mg) 156 ± 5.6 101 ± 6.1*** 138 ± 4.6# 124 ± 4.2##
Submandibular weight (mg) 288 ± 7.8 245 ± 13.8* 286 ± 7.2 234 ± 8.4**
Absolute salivary secretion (μL/7 min) 14.4 ± 0.6 6.7 ± 0.40*** 8.0 ± 0.81### 3.5 ± 0.18***###
Relative salivary secretion (μl/g tissue/min) 4.6 ± 0.05 2.7 ± 0.06*** 2.7 ± 0.07### 1.4 ± 0.02***###
Basal salivary glucose (mg/dL) 6.5 ± 0.32 23.4 ± 1.7*** 3.2 ± 0.30# 16.4 ± 1.3***###
Relative salivary secretion was calculated taking into account the sum of parotid and submandibular weights. Data are means ± S.E.M of 5 animals. *P < 0.05,
**P < 0.01 and ***P < 0.001 vs respective non-diabetic group; #P < 0.05, ##P < 0.01, ###P < 0.001 vs respective normotensive (WKY) group; One-Way ANOVA,
Student-Newman-Keuls post-test.
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reabsorption due to increased SGLT1 in the luminal
membrane. This is a reasonably expected result, and can
be compared to that observed in renal tubular glucose
handling of diabetic subjects, in which urinary glucose
increases, despite the increased glucose reabsorption by
increased SGLT2 expression [18]. That occurs because
glucose concentration in the glomerular filtrate is very
high. At a glance, we are proposing that in diabetic rats,
when plasma glucose concentration increases, the glucose
concentration in the primary saliva also increases, and
despite an increased ductal reabsorption, the glucose
concentration in the final saliva will remain high.
Submandibular
A B C D
E F G H
WKY                             WKY-D                              SHR                                 SHR-D
A B C D
E F G H
Saline+30m                         Saline+30m                   Propranolol+30m            Propranolol+30m
Non-stimulated                       Stimulated                   Non-stimulated                     Stimulated
Parotid 30minutes
A
B
Figure 1 Immunolocalization of the SGLT1 protein in ductal cells of salivary glands. A. SGLT1 protein in ductal cells of submandibular
glands of Wistar Kyoto rats (WKY), diabetic WKY (WKY-D), spontaneously hypertensive rats (SHR) and diabetic SHR (SHR-D). A to D: SGLT1 (green),
F-actin (red) and nuclear marker (blue). E to H: only SGLT1 in green color. The SGLT1 protein in ductal cells of WKY can be seen in a very low
intensity (A and E), whereas the SGLT1 immunoreactivity is clearly observed in WKY-D (B and F) and SHR (C and G); a further increase in SGLT1
can be observed in SHR-D (D and H). Arrowheads and arrows indicate the absence or presence of the SGLT1 protein in the luminal membrane of
ductal cells; respectively. Scale bar, 20 μm. Images are representative of 4 animals in each group. B. SGLT1 protein in ductal cells of the parotid
glands from Wistar-Kyoto rats that received physiological saline (A, B, E and F) or propranolol (C, D, G and H), and were subjected to 30-min
sympathetic stimulation (B, F, D and H) or not (A, E, C and G). A to D: SGLT1 (green), F-actin (red) and nuclear marker (blue); E to H: only SGLT1 in
green color. Scale bar, 20 μm. Arrowheads and arrows indicate the absence or presence of the SGLT1 protein in the luminal membrane of ductal
cells; respectively. Images are representative of 4 animals in each group.
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In summary, we are reporting that the SGLT1 protein
in the luminal membrane of ductal cells increases in
salivary glands from WKY-D, SHR and SHR-D rats,
inversely proportional to the non-stimulated salivary flow,
demonstrating the important water reabsorption role of
SGLT1 under these conditions. Furthermore, the luminal
membrane expression of SGLT1 in ductal cells increases
after sympathetic stimulus, which does not occur with
previous β-adrenergic blockade, evincing the sympathetic-
mediated regulation of SGLT1 translocation into the
luminal membrane. This diabetes- and/or hypertension-
induced increase in the ductal luminal SGLT1 protein, by
increasing salivary water reabsorption, may explain the
xerostomia reported by diabetic and hypertensive patients.
The present study, by pointing out the role of SGLT1
in the salivary water reabsorption, paves the way for the
future use of SGLT1 inhibitors in the treatment of
diabetic-and hypertensive-induced xerostomia.
Additional files
Additional file 1: Table S1. Body weight, 24-hour urinary glucose
excretion, plasma glucose, mean arterial pressure (MAP) and heart rate
(HR) of Wistar Kyoto rats (WKY), diabetic WKY (WKY-D), spontaneously
hypertensive rats (SHR) and diabetic SHR (SHR-D).
Additional file 2: Figure S1. Immunolocalization of SGLT1 protein in
ductal cells of parotid glands of Wistar Kyoto rats (WKY), diabetic WKY
(WKY-D), spontaneously hypertensive rats (SHR) and diabetic SHR (SHR-D).
A to D: SGLT1 (green), F-actin (red) and nuclear marker (blue). E to H: only
SGLT1 in green color. SGLT1 protein in ductal cells of WKY can be seen in
a very low intensity (A and E), whereas the SGLT1 immunoreactivity is
clearly observed in WKY-D (B and F) and SHR (C and G); a further increase
in SGLT1 can be observed in SHR-D (D and H). Arrowheads and arrows
indicate absence or presence of SGLT1 protein in luminal membrane of
ductal cells; respectively. Scale bar, 20 μm. Images are representative of 4
animals in each group.
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